EXC vs NDRA · P/E 17, rev $23.03B vs P/E 0.0, $2.6M cap
Exelon Corporation (EXC) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
NDRA does not have a complete income-statement cache yet.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the EXC and NDRA stock pages for the full models.
Not investment advice.